GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
  • American Association for Cancer Research (AACR)  (2)
  • McCormick, Frank  (2)
Material
Publisher
  • American Association for Cancer Research (AACR)  (2)
Language
Years
Subjects(RVK)
  • 1
    In: Cancer Research, American Association for Cancer Research (AACR), Vol. 70, No. 8_Supplement ( 2010-04-15), p. 3139-3139
    Abstract: [Objectives]: Activation of Ras/PI3-kinase (PI3K) pathway plays a direct causal role in human cancer. Oncogenic mutant Ras remains in active state, and activates various Ras effectors, including PI3K pathway. Ras/PI3K pathway activating mutations are very frequent in endometrial cancer, as reported at 35-55% for PTEN, 25-36% for PIK3CA and 10-20% for K-Ras. NF1 is a negative regulator of Ras and its alterations have been reported in several types of tumors. Although LOH at PTEN locus (10q23.3) is reported at 15-30%, other chromosomal imbalances involved in the Ras/PI3K pathway are not well characterized in endometrial cancer. In this study, we focused on chromosomal copy number alterations (CNAs), including copy number neutral (CNN) LOH, involved in the Ras/PI3K pathway in endometrial carcinomas. [Materials and Methods]: Under the approval of institutional ethical committees, we performed 250K or 50K Single Nucleotide Polymorphism (SNP) arrays in 31 endometrial carcinomas with paired DNA and examined allele-specific CNAs at K-Ras, NF1, PIK3CA and PTEN. [Results]: We detected deletions of PTEN locus in eight out of 31 (26%) tumors; one with homozygous deletions (HD), four with CNN LOH and three with LOH without gain of the opposite allele. In addition to one HD (3%) and three LOH (10%) at NF1 locus, we found gains at the loci of PIK3CA (3q26.3) in four (13%) tumors and K-Ras (12p12.1) in four (13%) tumors. Taken together, we detected 12 (39%) tumors with one or more CNAs involved in the Ras/PI3K pathway. All the four tumors with NF1 deletions coexist with other CNAs involved in the Ras/PI3K pathway (Table). [Conclusion] : Our data unveiled CNN LOH of PTEN and homozygous deletions of PTEN and NF1, which had not been reported by conventional CGH analysis. Various types of CNAs might play roles in activation of the Ras/PI3K pathway and targeting the Ras-PI3K pathway might be effective in endometrial carcinomas with the Ras-PI3K related CNAs.Table.Coexistent CN alterations in the Ras/PI3K pathwayPTEN (Loss)PIK3CA (Gain)K-Ras (Gain)NF1 (Loss)LOH Gain LOH  LOH Gain LOHLOHGain HDLOHGainGainLOH Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 101st Annual Meeting of the American Association for Cancer Research; 2010 Apr 17-21; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2010;70(8 Suppl):Abstract nr 3139.
    Type of Medium: Online Resource
    ISSN: 0008-5472 , 1538-7445
    RVK:
    RVK:
    Language: English
    Publisher: American Association for Cancer Research (AACR)
    Publication Date: 2010
    detail.hit.zdb_id: 2036785-5
    detail.hit.zdb_id: 1432-1
    detail.hit.zdb_id: 410466-3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    In: Cancer Research, American Association for Cancer Research (AACR), Vol. 70, No. 8_Supplement ( 2010-04-15), p. 2152-2152
    Abstract: [Objectives]: Endometrial cancer is one of the tumor types, in which either chromosomal instability (CIN) or microsatellite instability (MSI) may occur, and is known to possess mutations frequently in Ras-PI3K (phosphatidylinositol 3’-kinase) pathway. In this study, we attempted to clarify prognostic impact of genomic instability, determined by CIN and MSI status, and figure out the relationship between alterations in the Ras-PI3K pathway genes and the status of genomic instability. [Materials and Methods]: Under the approval of institutional ethical committees, we analyzed allele-specific chromosomal copy number alterations by SNP typing arrays in 31 endometrioid endometrial adenocarcinomas with paired DNA (25 by the 50K and six by the 250K probes). We also screened 25 of the 31 samples for MSI status with five microsatellite markers, and 22 samples for mutations in PIK3CA (exon 9 and 20), PTEN (exons 1-8) and K-Ras (exon1 and 2). Survival curves were constructed using the Kaplan-Meier method and compared with a log-rank test. [Results]: We detected five or more copy number changes (classified as CIN-extensive) in nine (29%), one to four changes (CIN-intermediate) in 17 (55%) and no changes (CIN-negative) in five (16%) tumors. Positive MSI was detected in ten (40%) of the 25 tumors and was less common in CIN-extensive tumors (14%), compared with CIN-intermediate/negative tumors (50%). CIN-extensive was signif icantly poor prognostic (p=0.0034), and the prognosis was shown to be independent from any other clinicpopathological characteristics by multivariate analysis. In contrast, positive MSI showed a trend to be a favorable prognostic factor (p=0.069), in spite of the association with vascular invasion (p=0.049). SNP array analysis unveiled copy number neutral LOH at 54 loci in 13 tumors (42%), including four at the locus of PTEN, and homozygous deletions at five regions in three tumors, including the locus of PTEN and NF1. Totally we detected eight (26%) tumors with PTEN deletions, and four (13%) with NF1 deletions. We identified mutations of PTEN, PIK3CA and K-Ras in 16 (73%), 6 (27%) and 2 (9%) out of 22 tumors, respectively. Seven (78%) of the nine CIN-extensive tumors harbor deletions at the loci of PTEN and/or NF1, with less frequent PTEN mutations (22%). On the other hand, PTEN mutations were detected in all the ten MSI-positive tumors, five of which coexist with PIK3CA and/or K-Ras mutations. We detected no deletions of NF1 and only one (10%) LOH of PTEN in the ten MSI-positive tumors. [Conclusion]: Our results demonstrated that the degree of CIN is a useful biomarker for prognosis in endometrial carcinomas. In addition, genomic alterations in the Ras-PI3K pathway are remarkably widespread in endometrial carcinomas, regardless of the type of genomic instability. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 101st Annual Meeting of the American Association for Cancer Research; 2010 Apr 17-21; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2010;70(8 Suppl):Abstract nr 2152.
    Type of Medium: Online Resource
    ISSN: 0008-5472 , 1538-7445
    RVK:
    RVK:
    Language: English
    Publisher: American Association for Cancer Research (AACR)
    Publication Date: 2010
    detail.hit.zdb_id: 2036785-5
    detail.hit.zdb_id: 1432-1
    detail.hit.zdb_id: 410466-3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...